Navigation Links
Eularis to Address Making the Right Research Decision for ROI

The Link Between Research and Decisions on Bottom Line Return at 3rd Annual

Pharmaceutical Market Research Summit

NEW YORK and LONDON, April 21 /PRNewswire/ -- Dr. Andree Bates, president of the pharmaceutical analytics company Eularis, will be delivering a presentation on Making the Right Research Decision for ROI -- The Link Between Research and Decisions on Bottom Line Return.
*(PHOTO 72dpi:

*(Photo Caption: Dr. Andree Bates, president of Eularis.)

WHO: Eularis

WHAT: Presentation on Making the Right Research Decision for ROI - The

Link Between Research and Decisions on Bottom Line Return

WHEN: 29 April 2008 at 11:45 a.m. EDT

WHERE: 3rd Annual Pharmaceutical Market Research Summit

Hyatt Regency at Penn's Landing, Philadelphia

At 11:45 a.m. on Tuesday, 29 April 2008, Dr. Bates will deliver a presentation titled, "How to Tell if You Are Making the Right Research Decision for ROI - The Link Between Research and Decisions on Bottom Line Return." Bates will challenge the conference attendees and will expose where both traditional market research and ROI can go wrong when used to guide marketing decisions return. She will also provide attendees with ideas on how to utilize market research data to provide input into ROI measurement for their marketing teams.

Bates has gained wide recognition within the international pharmaceutical industry for her expertise in marketing return analysis. Under Bates' leadership, Eularis issued three related research reports in the past year, including:

"Ensuring Profitable Return-on-Investment (ROI) in Pharmaceutical Marketing: Using Analytics and Metrics to Improve the Bottom Line" (,

"Pharmaceutical Sales Force Effectiveness Metrics: Are You Measuring the Wrong Things?" (, and

"Ensuring Profitable Patient Adherence Programs by Effectively Using Analytics to Release the Hidden Value Available to the Bottom Line from Adherence" (

The 3rd Annual Pharmaceutical Market Research Summit takes place in Philadelphia. The summit program features detailed case studies from some of the industry's most prominent organizations and provides information needed to improve market research initiatives.

About Eularis

Eularis provides sophisticated pharmaceutical analytics that provide data-driven insight into the financial impact of corporate and marketing decisions. Unlike traditional analytics approaches which are lengthy and whose reliance on historical or analogue data reduces their accuracy, Eularis' proprietary 94.8 Analytics Process is based on the current market situation. This proven approach helps pharmaceutical marketing teams to quickly plan, measure, validate, and optimize their sales and marketing performance. Eularis offers pre-launch analytics, marketing mix modeling (both professional and consumer), portfolio optimization, sales force effectiveness, managed care analytics, and patient compliance solutions. Co-headquartered in London and New York City, the company has developed significant experience in the global pharmaceutical market through client engagements with AstraZeneca, GlaxoSmithKline, Merck, Pfizer and many others.
For more information about Eularis, visit

All trademarks acknowledged.

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R).

SOURCE Eularis
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eularis Exposes Hidden Barriers to Patient Adherence With New Pharmaceutical Industry Report
2. MEDIA ALERT: Eularis to Address Marketing Return at Measuring Marketing ROI in Pharma Conference in London
3. MEDIA ALERT: Eularis to Address Marketing Return at Pharmaceutical Marketing Society Half-day Conference: ROI or RIP?
4. Eularis Releases Update of Its Comprehensive Report on Maximizing the Bottom Line in Pharmaceutical Marketing
5. Eularis Announces New Corporate Name and Expanded Product Offerings
6. Adaptis Launches New Website and URL Address
7. APIC Conference to Address New CMS Regulations
8. APIC Conference to address new CMS regulations
9. Siemens Addresses Cost vs. Value Issues In Healthcare and Technology
10. Video: National Association of School Nurses Launches Educational Program to Address Surge of Prescription Drug Abuse by Americas Youth
11. AWWA Urges Science-Based Approach in Addressing Pharmaceutical Compounds in Water
Post Your Comments:
(Date:11/25/2015)... ... ... The holiday season is jam-packed with family dinners, parties ... is of the utmost importance. Whether you are cooking at home for the ... try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the ... loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and ... hair, without the need for surgery, prescription pills, or topical foams. , “Capillus272™ ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... for physicians and athletic programs, launches new Wimbledon Athletics Facebook page ... testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under the age ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, ... facial plastic surgeon specializing in both surgical and non-surgical treatments, announced the expansion ... at Hobgood Facial Plastic Surgery. , Highly trained and nationally recognized for ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 /PRNewswire/ ... --> Juntendo universitetssjukhus ser potential att ... av magnetresonansbilder (MR-bilder) för patienter med ... tecknat ett forskningsavtal med SyntheticMR AB för ... kliniska forskningsprojekt på sjukhuset. Med SyMRI kan ...
(Date:11/26/2015)... , November 26, 2015 ... --> adds "Global Repaglinide ... "Investigation Report on China Repaglinide Market, ... forecasts data and information to its ... . --> ...
Breaking Medicine Technology: